X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3725) 3725
Magazine Article (20) 20
Newspaper Article (15) 15
Newsletter (10) 10
Book Chapter (8) 8
Dissertation (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (2687) 2687
humans (2678) 2678
life sciences & biomedicine (2587) 2587
minocycline - therapeutic use (2409) 2409
male (1647) 1647
anti-bacterial agents - therapeutic use (1365) 1365
minocycline (1321) 1321
female (1309) 1309
animals (1052) 1052
minocycline - pharmacology (1010) 1010
adult (870) 870
minocycline - analogs & derivatives (808) 808
middle aged (785) 785
pharmacology & pharmacy (688) 688
minocycline - administration & dosage (582) 582
microbiology (572) 572
anti-bacterial agents - pharmacology (570) 570
neurosciences & neurology (537) 537
infectious diseases (530) 530
aged (518) 518
treatment outcome (516) 516
minocycline - adverse effects (488) 488
neurosciences (473) 473
microbial sensitivity tests (429) 429
rats (373) 373
mice (369) 369
tigecycline (364) 364
adolescent (347) 347
anti-bacterial agents - administration & dosage (346) 346
disease models, animal (344) 344
antibiotics (342) 342
drug therapy, combination (326) 326
dermatology (319) 319
anti-bacterial agents - adverse effects (315) 315
abridged index medicus (268) 268
analysis (245) 245
health aspects (243) 243
research (241) 241
microglia (222) 222
inflammation (221) 221
dentistry (218) 218
drug therapy (217) 217
time factors (209) 209
acne vulgaris - drug therapy (207) 207
clinical neurology (207) 207
microglia - drug effects (200) 200
immunology (198) 198
care and treatment (196) 196
rats, sprague-dawley (195) 195
drug resistance, multiple, bacterial (191) 191
aged, 80 and over (178) 178
general & internal medicine (173) 173
tetracyclines - therapeutic use (170) 170
child (169) 169
infectious disease (168) 168
neurology (157) 157
young adult (154) 154
follow-up studies (151) 151
neuroprotective agents - therapeutic use (148) 148
drug resistance (144) 144
acinetobacter baumannii - drug effects (142) 142
dentistry, oral surgery & medicine (139) 139
infections (139) 139
drug resistance, bacterial (138) 138
acinetobacter infections - drug therapy (137) 137
dose-response relationship, drug (136) 136
rifampin - therapeutic use (136) 136
bacteria (135) 135
clinical trials (132) 132
retrospective studies (132) 132
rodents (132) 132
minocycline - pharmacokinetics (129) 129
rats, wistar (129) 129
research article (127) 127
medicine, general & internal (126) 126
bacterial infections - drug therapy (125) 125
dosage and administration (124) 124
doxycycline - therapeutic use (123) 123
medicine (123) 123
administration, oral (122) 122
double-blind method (120) 120
neuroprotective agents - pharmacology (120) 120
psychiatry (118) 118
clinical trials as topic (117) 117
apoptosis (116) 116
internal medicine (116) 116
microglia - metabolism (116) 116
surgery (115) 115
oncology (113) 113
neuroprotection (112) 112
cytokines (111) 111
medicine & public health (111) 111
mice, inbred c57bl (110) 110
risk factors (107) 107
drug combinations (106) 106
acinetobacter infections - microbiology (105) 105
pneumonia (105) 105
drug resistance in microorganisms (103) 103
pathology (103) 103
tetracycline - therapeutic use (102) 102
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3552) 3552
Japanese (122) 122
French (71) 71
German (36) 36
Spanish (29) 29
Chinese (23) 23
Italian (21) 21
Dutch (12) 12
Portuguese (10) 10
Russian (6) 6
Czech (5) 5
Hebrew (3) 3
Turkish (3) 3
Norwegian (2) 2
Danish (1) 1
Finnish (1) 1
Korean (1) 1
Polish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Medical clinics of North America, ISSN 0025-7125, 05/2012, Volume 96, Issue 3, pp. 475 - 496
Over the past several decades, rheumatology has directed its focus to understanding and countering the immune dysregulation underlying autoimmune diseases with... 
Biologic response modifiers | Systemic lupus erythematosus | Vasculitis | Disease-modifying antirheumatic drugs | Biologics | Rheumatoid arthritis | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hydroxychloroquine - therapeutic use | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Certolizumab Pegol | Rheumatic Diseases - drug therapy | Colchicine - therapeutic use | Humans | Recombinant Fusion Proteins - therapeutic use | Antibodies, Monoclonal - therapeutic use | Immunoglobulin Fab Fragments - therapeutic use | Methotrexate - therapeutic use | Polyethylene Glycols - therapeutic use | Cyclophosphamide - therapeutic use | Receptors, Tumor Necrosis Factor - therapeutic use | Abatacept | Etanercept | Infliximab | Minocycline - therapeutic use | Immunoconjugates - therapeutic use | Antirheumatic Agents - therapeutic use | Rheumatic Diseases - immunology | Sulfasalazine - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Immunoglobulin G - therapeutic use | Rituximab | Cyclosporine - therapeutic use | Interleukin 1 Receptor Antagonist Protein - therapeutic use | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Isoxazoles - therapeutic use | Adalimumab | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Tumor Necrosis Factors - antagonists & inhibitors
Journal Article
International journal of stroke, ISSN 1747-4949, 03/2012, Volume 7, Issue 5, pp. 407 - 418
Neuroprotection seeks to restrict injury to the brain parenchyma following an ischaemic insult by preventing salvageable neurons from dying. The concept of... 
ischaemic cascade | translation | STAIR | ischaemic stroke | acute stroke therapy | neuroprotection | Neuroprotection | Translation | Acute stroke therapy | Ischaemic cascade | Ischaemic stroke | Clinical Neurology | Peripheral Vascular Disease | Neurosciences & Neurology | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Neuroprotective Agents - therapeutic use | Minocycline - pharmacology | Humans | Egtazic Acid - therapeutic use | Benzenesulfonates - therapeutic use | Benzenesulfonates - pharmacology | Neuroprotective Agents - pharmacology | Minocycline - therapeutic use | Pregnatrienes - therapeutic use | Hypothermia, Induced - methods | Egtazic Acid - analogs & derivatives | Thrombolytic Therapy - methods | Drug Evaluation, Preclinical | Chelating Agents - therapeutic use | Stroke - therapy | Disease Models, Animal | Hematopoietic Cell Growth Factors - therapeutic use | Acute Disease | NADPH Oxidases - antagonists & inhibitors | Translational Medical Research | Clinical Trials as Topic | Combined Modality Therapy | Pregnatrienes - pharmacology | Chelating Agents - pharmacology | Magnesium - pharmacology | Magnesium - therapeutic use | Serum Albumin - therapeutic use | Animals | Egtazic Acid - pharmacology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Serum Albumin - pharmacology | Brain Ischemia - drug therapy | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Hematopoietic Cell Growth Factors - pharmacology | Diffusion of Innovation | Index Medicus | Oxygen | Stroke | Free radicals | Neurons | Standardization | Albumin | Clinical trials | Parenchyma | Glucose | Neuroprotective agents | NAD(P)H oxidase | Cell death | thrombolysis | Growth factors | Brain injury | Hypothermia
Journal Article
Journal of endodontics, ISSN 0099-2399, 10/2009, Volume 35, Issue 10, pp. 1343 - 1349
..., the remaining thin fragile dentinal walls predispose these teeth to fracture. Moreover, some studies have shown that long-term use of calcium hydroxide can weaken dentin (2... 
Endocrinology & Metabolism | Dentistry | retrospective studies | regenerative endodontics | revascularization | Immature teeth | Life Sciences & Biomedicine | Dentistry, Oral Surgery & Medicine | Science & Technology | Formocresols - therapeutic use | Follow-Up Studies | Apexification | Humans | Dental Pulp Cavity - diagnostic imaging | Dental Pulp Necrosis - therapy | Silicates - therapeutic use | Aluminum Compounds - therapeutic use | Anti-Bacterial Agents - therapeutic use | Dental Pulp - diagnostic imaging | Odontometry - methods | Calcium Compounds - therapeutic use | Guided Tissue Regeneration - methods | Dentinogenesis - physiology | Minocycline - administration & dosage | Retrospective Studies | Dental Pulp - physiopathology | Dentin - diagnostic imaging | Oxides - therapeutic use | Dentin - physiopathology | Root Canal Therapy | Metronidazole - administration & dosage | Dental Pulp Cavity - physiopathology | Root Canal Irrigants - therapeutic use | Treatment Outcome | Image Processing, Computer-Assisted - methods | Root Canal Filling Materials - therapeutic use | Tooth Apex - diagnostic imaging | Radiography | Ciprofloxacin - administration & dosage | Calcium Hydroxide - therapeutic use | Tooth Cervix - diagnostic imaging | Dental Pulp Necrosis - diagnostic imaging | Odontogenesis - physiology | Anti-Bacterial Agents - administration & dosage | Drug Combinations | Tooth Apex - physiopathology | Analysis | Root canal therapy
Journal Article
Journal Article